Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
Regenerative Drugbased Cardiac Therapies
Clinical Research V5 I4

Regenerative Drugbased Cardiac Therapies

Myocardial infarction results from the interruption of blood supply to a part of the heart, causing heart cells to die. This is most due to coronary artery...
Continue Reading →
IPI Interviews Dr Chitra Lele
Clinical Research V5 I4

IPI Interviews Dr Chitra Lele

IPI Interviews Dr Chitra Lele - The Chief Scientific Officer at Sciformix Corporation. https://international-pharma.com/wp-content/uploads/2014/01/IPI-Interviews.1.p...
Continue Reading →
Hyaluronic Acid – Creation of Slow Release Formulations for Osteoarthritis Treatments
Clinical Research V5 I4

Hyaluronic Acid – Creation of Slow Release Formulations for Osteoarthritis Treatments

Osteoarthritis (OA) is the world’s most common degenerative joint disorder, affecting more than 60% of the population over the age of 65.During this condition, bone ...
Continue Reading →
A New Future for Antibiotics?
Clinical Research V5 I4

A New Future for Antibiotics?

A future without antibiotics is deemed to be bleak, if bacteria continue to develop new resistance mechanisms and the pharmaceutical industry have to produce novel c...
Continue Reading →
Screening Kidney Function in People With Carotid Artery Disease May Help In Development Of Early Intervention Strategies
Clinical Research V5 I4

Screening Kidney Function in People With Carotid Artery Disease May Help In Development Of Early Intervention Strategies

Chronic kidney disease (CKD) is a progressive reduction in the kidneys’ ability to filter blood. People with CKD have greatly increased mortality risk in comparison ...
Continue Reading →
Proactive Safety Management for Established Healthcare Products
Clinical Research V5 I4

Proactive Safety Management for Established Healthcare Products

A recent analysis shows that more than $290 billion of prescription drug sales are at risk from patent expirations between 2011 and 2018. Chitra Lele at Sciformix di...
Continue Reading →
Critical Thinking on Criticality
Clinical Research V5 I4

Critical Thinking on Criticality

“Critical” is a widely used term in Quality by Design, relating to anything which affects the safety or efficacy of the finished product. Dr. Brian Carlin at FMC Bio...
Continue Reading →
Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025